QLS Logistics & Transportation

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

QLS Logistics & Transportation - overview

Established

2015

Location

Coopersville, MI, US

Primary Industry

Logistics & Distribution

About

Quality Life Science Logistics, LLC, dba QLS Logistics & Transportation is a US-based company specializing in logistics and transportation solutions for the pharmaceutical and life sciences sectors, ensuring secure and timely delivery of products. Founded in 2015 and headquartered in Coopersville, US, by CEO Terry Fewless QLS Logistics & Transportation focuses on providing specialized logistics services. In November 2025, Bluejay Capital, along with the companies management acquired QLS Logistics & Transportation, as part of recapitalization. Quality Life Science Logistics & Transportation (QLS) is a leading provider of specialized logistics and transportation solutions specifically tailored for the pharmaceutical and life sciences sectors.


Their core offerings encompass comprehensive logistics management, temperature-sensitive transportation services, and cold chain logistics, ensuring the integrity and security of pharmaceutical products throughout the supply chain. Utilizing advanced technology and a skilled team, QLS coordinates logistics with trusted carriers and operates its own fleet, serving clients primarily across the United States and Canada. QLS generates revenue primarily through B2B transactions, providing logistics and transportation services to pharmaceutical and life sciences clients under contracts that ensure the safe handling and timely delivery of products. The company’s pricing structure is typically based on service agreements that may involve fixed contracts or variable pricing models depending on shipment specifics, such as temperature requirements or freight type.


QLS's flagship services are integral to its revenue model, capitalizing on the growing demand for reliable cold chain logistics and transportation solutions in the pharmaceutical industry. In November 2025, funding will enable the company to expand its market reach and strengthen its position in the cold chain logistics sector. The recent acquisition supports QLS's strategy to enhance its service offerings and penetrate new geographic markets, although specific upcoming products or services have not been outlined. The company's focus remains on leveraging this acquisition to solidify its presence in the industry.


Current Investors

Bluejay Capital

Primary Industry

Logistics & Distribution

Sub Industries

Transportation Services, Trucking, Warehouses, Web Applications, Logistics Software, Analytics & Performance Software

Website

www.goqls.com

Verticals

Artificial Intelligence, Cloud Computing

Company Stage

Mature

Total Amount Raised

Subscriber access only

QLS Logistics & Transportation - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
RecapitalisationCompletedQLS Logistics & Transportation-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.